Newbridge Financial Services Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,700
| Closed | -$39.8K | – | 1182 |
|
|
2024
Q3 | $39.8K | Sell |
1,700
-1,384
| -45% | -$32.4K | 0.01% | 276 |
|
|
2024
Q2 | $54.9K | Sell |
3,084
-578
| -16% | -$10.3K | 0.02% | 360 |
|
|
2024
Q1 | $55.7K | Sell |
3,662
-1,150
| -24% | -$17.5K | 0.02% | 377 |
|
|
2023
Q4 | $82.2K | Sell |
4,812
-446
| -8% | -$7.62K | 0.04% | 306 |
|
|
2023
Q3 | $44K | Buy |
5,258
+1,312
| +33% | +$11K | 0.02% | 437 |
|
|
2023
Q2 | $98K | Sell |
3,946
-500
| -11% | -$12.4K | 0.05% | 318 |
|
|
2023
Q1 | $66.9K | Buy |
4,446
+174
| +4% | +$2.62K | 0.04% | 399 |
|
|
2022
Q4 | $50.5K | Sell |
4,272
-1,362
| -24% | -$16.1K | 0.03% | 459 |
|
|
2022
Q3 | $33K | Buy |
5,634
+962
| +21% | +$5.64K | 0.02% | 566 |
|
|
2022
Q2 | $20K | Sell |
4,672
-380
| -8% | -$1.63K | 0.01% | 664 |
|
|
2022
Q1 | $48K | Hold |
5,052
| – | – | 0.02% | 488 |
|
|
2021
Q4 | $96K | Sell |
5,052
-192
| -4% | -$3.65K | 0.05% | 318 |
|
|
2021
Q3 | $175K | Sell |
5,244
-378
| -7% | -$12.6K | 0.11% | 188 |
|
|
2021
Q2 | $218K | Sell |
5,622
-193
| -3% | -$7.48K | 0.13% | 167 |
|
|
2021
Q1 | $280K | Buy |
5,815
+5,306
| +1,042% | +$255K | 0.21% | 119 |
|
|
2020
Q4 | $26K | Buy |
+509
| New | +$26K | 0.02% | 478 |
|